Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders

 
 

LA JOLLA PHARMACEUTICAL CO (LJPC) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $4.88 Metrics
OS: 24.9 M
Market cap: $122 M -44 % ROIC
Net cash: $48.7 M $1.95 per share
EV: $73 M

 
TTM Valuation
EBITDA ($916.0) k
EBIT ($2.6) M
EPS $0.10 46.6 x P/E

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
Revenues75.733.423.110.10.00.61.10.0
            Revenue growth126.6%45.0%129.3% -100.0%-41.7%  
Cost of goods sold13.57.82.41.6-1.6-0.50.80.5
Gross profit62.225.620.78.41.61.10.3-0.5
            Gross margin82.2%76.6%89.6%83.7% 181.2%24.3% 
Selling, general and administrative35.438.445.185.230.916.7  
Research and development5.023.085.3117.386.262.829.19.9
General and administrative      13.911.4
EBITA23.4-35.2-109.8-194.1-115.4-78.4-42.0-21.3
            EBITA margin30.9%-105.3%-476.3%-1929.7% -12722.7%-3970.6% 
Amortization of intangibles1.60.6      
EBIT21.8-35.8-109.8-194.1-115.4-78.4-42.0-21.3
            EBIT margin28.8%-107.2%-476.3%-1929.7% -12722.7%-3970.6% 
Pre-tax income19.7-39.4-116.5-199.5-114.8-78.2-41.9-21.3
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.2%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income19.7-39.4-116.5-199.5-114.8-78.2-41.9-21.3
            Net margin26.0%-118.0%-505.4%-1983.6% -12692.4%-3965.2% 
 
Diluted EPS$0.58($1.44)($4.30)($7.85)($5.41)($4.54)($2.68)($2.00)
Shares outstanding (diluted)34.227.327.125.421.217.215.710.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy